GE医疗科技公司最新财报显示,其第四季度调整后每股收益达到1.44美元,显著超越市场研究机构IBES此前预估的1.4美元水平。这一业绩表现凸显了公司在医疗设备领域的强劲盈利能力。
不过值得注意的是,根据通用会计准则计算的第四季度每股收益为1.29美元,与调整后数据存在一定差异。财报数据的发布时间为2月4日09:54(格林威治标准时间)。
GE医疗科技公司最新财报显示,其第四季度调整后每股收益达到1.44美元,显著超越市场研究机构IBES此前预估的1.4美元水平。这一业绩表现凸显了公司在医疗设备领域的强劲盈利能力。
不过值得注意的是,根据通用会计准则计算的第四季度每股收益为1.29美元,与调整后数据存在一定差异。财报数据的发布时间为2月4日09:54(格林威治标准时间)。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.